Class I — Most Severe

TRUE METRIX Glucose Meters: Label Update for E-5 Error

FreshRecall Team Trividia Health, Inc. Labeling Issue

This recall was posted 1 month ago. Check the FDA source for the latest status.

Class I Recall — Most Serious

This is a Class I recall — the most serious type. Products covered by this recall may cause serious health consequences or death.

Reported Health Impact

114

Illnesses

1

Death

"Image of E-5 error code on screen" "Image of E-5 error code on screen"

Trividia Health, Inc. has announced a labeling update for all TRUE METRIX Blood Glucose Monitoring Systems due to a critical instruction regarding the E-5 error code. This update affects devices distributed in the U.S., U.K., Mexico, Australia, and the Caribbean.

Affected Products:

  • TRUE METRIX
  • TRUE METRIX AIR
  • TRUE METRIX GO
  • TRUE METRIX PRO

Reason for Recall:

The current instructions do not emphasize the need for immediate medical attention if users experience symptoms of high glucose and receive an E-5 error code. This error indicates a very high blood glucose level (> 600 mg/dL) or a test strip error. Delayed treatment could lead to serious health consequences or death.

What Consumers Should Do:

  • Retest with a new test strip if an E-5 error appears.
  • If symptoms such as fatigue, excess urination, thirst, or blurry vision occur, seek medical attention immediately.
  • If no symptoms are present, retest with a new strip. If the error persists, contact Trividia Health at 1-800-803-6025.

Health Risks:

Since 2014, there have been 114 reported serious injuries and one death linked to the E-5 error code.

For further information, contact Trividia Health Customer Care at 1-888-835-2723 or visit their website. Consumers can continue using the meters; no product returns or replacements are necessary. Report any adverse reactions to the FDA's MedWatch Program.

Affected Products

Product Name
Blood Glucose Monitoring Systems
Blood Glucose Monitoring Systems

Where Products Were Sold

This recall affects products distributed nationwide across the United States.

Contact Information

Media Contact

Annmarie Ramos

Tags

View original FDA announcement